Publications by authors named "Zoe Zuilhof"
Article Synopsis
- Digital technologies can objectively detect symptoms of depression, allowing for the collection of extensive relevant data that traditional methods may miss.
- A study was conducted with 20 participants having unipolar depression and 20 healthy controls to test the effectiveness of several digital technologies as potential diagnostic tools.
- Various digital assessments were used, both in-clinic and through mobile apps, including mood self-assessments, cognitive tests, behavioral monitoring, and advanced neural analysis techniques.
Introduction: This study investigated if optimized dose regimens of escitalopram and bupropion combination from treatment initiation can be superior to either drug alone in speed of onset, remission rate, and maintenance of therapeutic efficacy.
Methods: Patients from a single site (N=85) within a larger double-blind 12-week trial (N=245) showed a lower dropout rate (14% vs 40%) and used higher doses; therefore, this cohort was analyzed separately. Uniquely at this single site, after 12 weeks, non-remitters on a single drug received the other one in addition and combination non-remitters underwent a switch of escitalopram for duloxetine for a 6-week period.